BRPI0606187A2 - comprimidos com capacidade de dispersão da substáncia do fármaco melhorada - Google Patents
comprimidos com capacidade de dispersão da substáncia do fármaco melhoradaInfo
- Publication number
- BRPI0606187A2 BRPI0606187A2 BRPI0606187-7A BRPI0606187A BRPI0606187A2 BR PI0606187 A2 BRPI0606187 A2 BR PI0606187A2 BR PI0606187 A BRPI0606187 A BR PI0606187A BR PI0606187 A2 BRPI0606187 A2 BR PI0606187A2
- Authority
- BR
- Brazil
- Prior art keywords
- drug substance
- tablets
- improved drug
- vehicle
- dispersibility
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
- A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
Abstract
COMPRIMIDOS COM CAPACIDADE DE DISPERSãO DA SUBSTáNCIA DO FáRMACO MELHORADA. A presente invenção refere-se a um método para a preparação de composições farmacêuticas na forma de comprimidos com capacidade de dispersão da substância do fármaco melhorada, o referido método sendo caracterizado pelo fato de que ele compreende as etapas de: a) preparar uma dispersão de pelo menos uma substância de fármaco farmaceuticamente ativa e pelo menos um tensoativo e/ou ligante em um líquido; b) preparar um veículo pela aglutinação a seco de um ou mais excipiente(s) incluindo pelo menos um veículo poroso; e c) granular por pulverização a dispersão preparada sob a) por cima do veículo preparado sob b) com a finalidade de ser obtido um produto granulado por pulverização.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP05101458 | 2005-02-25 | ||
PCT/EP2006/001395 WO2006089674A2 (en) | 2005-02-25 | 2006-02-16 | Tablets with improved drug substance dispersibility |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI0606187A2 true BRPI0606187A2 (pt) | 2009-06-09 |
Family
ID=36406213
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0606187-7A BRPI0606187A2 (pt) | 2005-02-25 | 2006-02-16 | comprimidos com capacidade de dispersão da substáncia do fármaco melhorada |
Country Status (20)
Country | Link |
---|---|
US (2) | US20060193910A1 (pt) |
EP (2) | EP1855655A2 (pt) |
JP (1) | JP2008531509A (pt) |
KR (1) | KR20070094666A (pt) |
CN (1) | CN101128189A (pt) |
AR (1) | AR055561A1 (pt) |
AU (1) | AU2006218193A1 (pt) |
BR (1) | BRPI0606187A2 (pt) |
CA (1) | CA2598762A1 (pt) |
CR (1) | CR9292A (pt) |
IL (1) | IL185011A0 (pt) |
MA (1) | MA29268B1 (pt) |
MX (1) | MX2007009571A (pt) |
NO (1) | NO20074092L (pt) |
NZ (1) | NZ560232A (pt) |
RU (1) | RU2007129642A (pt) |
TW (1) | TW200640502A (pt) |
UA (1) | UA90708C2 (pt) |
WO (1) | WO2006089674A2 (pt) |
ZA (1) | ZA200706495B (pt) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10026698A1 (de) | 2000-05-30 | 2001-12-06 | Basf Ag | Selbstemulgierende Wirkstoffformulierung und Verwendung dieser Formulierung |
GB0123400D0 (en) | 2001-09-28 | 2001-11-21 | Novartis Ag | Organic compounds |
US8025899B2 (en) | 2003-08-28 | 2011-09-27 | Abbott Laboratories | Solid pharmaceutical dosage form |
US8377952B2 (en) | 2003-08-28 | 2013-02-19 | Abbott Laboratories | Solid pharmaceutical dosage formulation |
EP2018157A2 (en) * | 2006-04-26 | 2009-01-28 | Astron Research Limited | Controlled release formulation comprising anti-epileptic drugs |
BRPI0818317A8 (pt) * | 2007-10-10 | 2018-12-18 | Mallinckrodt Baker Inc | composição, métodos de fabricação de excipiente, comprimido farmacêutico e método de fabricação do mesmo |
US20100055180A1 (en) * | 2007-10-10 | 2010-03-04 | Mallinckrodt Baker, Inc. | Directly Compressible Granular Microcrystalline Cellulose Based Excipient, Manufacturing Process and Use Thereof |
DE102008047910A1 (de) | 2008-09-19 | 2010-03-25 | Molkerei Meggle Wasserburg Gmbh & Co. Kg | Tablettierhilfsstoff auf Laktose- und Cellulosebasis |
SG173058A1 (en) * | 2009-01-23 | 2011-08-29 | Hoffmann La Roche | Pharmaceutical composition comprising aleglitazar |
EP2722045B1 (en) | 2009-11-18 | 2016-07-06 | Helsinn Healthcare SA | Compositions for treating centrally mediated nausea and vomiting |
CN102641302B (zh) * | 2011-02-18 | 2016-01-20 | 上海张江中药现代制剂技术工程研究中心 | 一种提高中药提取物浸膏粉软化点的方法 |
RU2468789C1 (ru) * | 2011-05-04 | 2012-12-10 | Федеральное государственное бюджетное учреждение науки Иркутский институт химии им. А.Е. Фаворского Сибирского отделения Российской академии наук (ИрИХ СО РАН) | Средство для профилактики и лечения атеросклероза |
CN104784239B (zh) * | 2015-04-28 | 2017-12-26 | 新乡医学院第一附属医院 | 一种快速溶出的珍菊降压片及其制备工艺 |
KR20170003414A (ko) * | 2015-06-30 | 2017-01-09 | (주)아모레퍼시픽 | 속붕해형 과립환 모발 세정용 조성물 |
WO2017003137A1 (ko) * | 2015-06-30 | 2017-01-05 | (주)아모레퍼시픽 | 속붕해형 과립환 모발 세정용 조성물 |
JP2020500176A (ja) | 2016-11-16 | 2020-01-09 | ルンドベック ラ ホーヤ リサーチ センター,インク. | 医薬製剤 |
CN109701441B (zh) * | 2018-12-16 | 2021-04-09 | 桂林理工大学 | 一种卵磷脂选择性改性高岭石的制备方法及其应用 |
TWI728709B (zh) * | 2020-02-19 | 2021-05-21 | 台灣森本生物科技開發股份有限公司 | 含有得自於藤黃樹脂的丙酮萃取產物的藥學組成物以及由該組成物所製得的配方 |
CN111548218A (zh) * | 2020-04-27 | 2020-08-18 | 上海应用技术大学 | 一种通用型花肥速释片及其制备方法和应用 |
Family Cites Families (49)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2671970B1 (fr) * | 1991-01-30 | 1995-06-23 | Wellcome Found | Comprimes dispersables dans l'eau. |
ATE195867T1 (de) | 1991-09-20 | 2000-09-15 | Glaxo Group Ltd | Neue medizinische indikation für tachykinin- antagonisten |
DE69530308T2 (de) * | 1994-09-22 | 2003-10-16 | Akzo Nobel Nv | Verfahren zur herstellung von dosierungsformen durch feuchtgranulierung |
US6106865A (en) * | 1995-01-09 | 2000-08-22 | Edward Mendell Co., Inc. | Pharmaceutical excipient having improved compressibility |
IT1276160B1 (it) * | 1995-11-22 | 1997-10-27 | Recordati Chem Pharm | Composizioni farmaceutiche orali a pronto rilascio per sospensioni estemporanee |
ATE288756T1 (de) | 1996-12-02 | 2005-02-15 | Merck Sharp & Dohme | Verwendung von nk-1 rezeptorantagonisten zur behandlung von schweren depressionen, die von angstzuständen begleitet werden |
CA2273810A1 (en) | 1996-12-02 | 1998-06-11 | Merck Sharp & Dohme Limited | Use of nk-1 receptor antagonists for treating major depressive disorders |
FR2758459B1 (fr) * | 1997-01-17 | 1999-05-07 | Pharma Pass | Composition pharmaceutique de fenofibrate presentant une biodisponibilite elevee et son procede de preparation |
JP4367723B2 (ja) * | 1997-08-25 | 2009-11-18 | 大正製薬株式会社 | 水難溶性成分を配合した固形剤 |
GB9825242D0 (en) | 1998-11-19 | 1999-01-13 | Cambridge Advanced Tech | Genetically modified plants with altered starch |
PE20001302A1 (es) * | 1998-11-27 | 2000-11-30 | Hoffmann La Roche | Preparaciones de una combinacion farmaceutica que contiene carvedilol e hidroclorotiazida |
EP1157006B1 (en) | 1999-02-24 | 2006-10-25 | F. Hoffmann-La Roche Ag | Phenyl- and pyridinyl derivatives as neurokinin 1 antagonists |
SI1157005T1 (en) | 1999-02-24 | 2005-02-28 | F. Hoffmann-La Roche Ag | 3-phenylpyridine derivatives and their use as nk-1 receptor antagonists |
ATE496032T1 (de) | 1999-02-24 | 2011-02-15 | Hoffmann La Roche | 4-phenylpyridinderivate und deren verwendung als nk-1 rezeptorantagonisten |
JP3702182B2 (ja) | 1999-03-06 | 2005-10-05 | ロシュ ダイアグノスティックス ゲーエムベーハー | ピロバクルム・イスランジカム(Pyrobaculumislandicum)由来のDNAポリメラーゼ |
US6274588B1 (en) | 1999-05-31 | 2001-08-14 | Hoffmann-La Roche Inc. | 4-phenyl-pyrimidine derivatives |
JO2308B1 (en) | 1999-05-31 | 2005-09-12 | اف. هوفمان- لاروش أيه جي | Derivatives of phenylpyrmidine |
US7863331B2 (en) * | 1999-07-09 | 2011-01-04 | Ethypharm | Pharmaceutical composition containing fenofibrate and method for the preparation thereof |
FR2795961B1 (fr) * | 1999-07-09 | 2004-05-28 | Ethypharm Lab Prod Ethiques | Composition pharmaceutique contenant du fenofibrate micronise, un tensioactif et un derive cellulosique liant et procede de preparation |
PT1103545E (pt) | 1999-11-29 | 2004-03-31 | Hoffmann La Roche | 2-(3,5-bis-trifluorometil-fenil)-n-metil-n-(6-morfolin-4-il-4-o-totil-piridin-3-il)-isobutiramida |
US6303790B1 (en) | 1999-11-29 | 2001-10-16 | Hoffman-La Roche Inc. | Process for the preparation of pyridine derivatives |
AUPQ514600A0 (en) | 2000-01-18 | 2000-02-10 | James Cook University | Brain injury treatment |
US6452001B2 (en) | 2000-05-25 | 2002-09-17 | Hoffmann-La Roche Inc. | Diazapane derivatives useful as antagonists of neurokinin 1 receptor and methods for their formation |
US6482829B2 (en) | 2000-06-08 | 2002-11-19 | Hoffmann-La Roche Inc. | Substituted heterocyclic siprodecane compound active as an antagonist of neurokinin 1 receptor |
NZ523273A (en) | 2000-07-14 | 2004-08-27 | F | N-oxides as NK1 receptor antagonist prodrugs of 4-phenyl-pyridine derivatives |
TWI287003B (en) | 2000-07-24 | 2007-09-21 | Hoffmann La Roche | 4-phenyl-pyridine derivatives |
TWI259180B (en) | 2000-08-08 | 2006-08-01 | Hoffmann La Roche | 4-Phenyl-pyridine derivatives |
YU39503A (sh) | 2000-11-22 | 2006-05-25 | F. Hoffmann-La Roche Ag. | Derivati pirimidina |
PT1349541E (pt) | 2000-12-14 | 2007-01-31 | Hoffmann La Roche | Matriz lipídica auto-emulsionante (selm) |
US6642226B2 (en) | 2001-02-06 | 2003-11-04 | Hoffman-La Roche Inc. | Substituted phenyl-piperidine methanone compounds |
US6531597B2 (en) | 2001-02-13 | 2003-03-11 | Hoffmann-La Roche Inc. | Process for preparation of 2-phenyl acetic acid derivatives |
PT1385577E (pt) | 2001-04-23 | 2006-08-31 | Hoffmann La Roche | Utilizacao de antagonistas do receptor nk-1 contra a hiperplasia prostatica benigna |
DE60227657D1 (de) | 2001-05-14 | 2008-08-28 | Hoffmann La Roche | 1-OXA-3,9-DIAZASPIROc5.5ÜUNDECAN-2-ONDERIVATE UND ZEPTORS |
US20030083345A1 (en) | 2001-07-10 | 2003-05-01 | Torsten Hoffmann | Method of treatment and/or prevention of brain, spinal or nerve injury |
US6849624B2 (en) | 2001-07-31 | 2005-02-01 | Hoffmann-La Roche Inc. | Aromatic and heteroaromatic substituted amides |
US6667327B2 (en) | 2002-02-04 | 2003-12-23 | Hoffmann-La Roche Inc. | Pyridine amido derivatives |
US6660736B2 (en) | 2002-03-27 | 2003-12-09 | Hoffmann-La Roche Inc. | Phthalimido derivatives and a process for their preparation |
KR100681585B1 (ko) | 2002-04-26 | 2007-02-09 | 에프. 호프만-라 로슈 아게 | 아이소퀴놀린 유도체 |
PL212708B1 (pl) | 2002-05-29 | 2012-11-30 | Hoffmann La Roche | Pochodne N-acyloaminobenzenu, sposób ich wytwarzania, lek zawierajacy te pochodne i zastosowanie pochodnych N-acyloaminobenzenu |
KR20030095600A (ko) * | 2002-06-12 | 2003-12-24 | 환인제약 주식회사 | 펠로디핀을 포함하는 제어방출형 조성물 및 그 제조방법 |
US6951884B2 (en) | 2002-06-12 | 2005-10-04 | Hoffmann-La Roche Inc. | Fluorobenzamides and uses thereof |
US6900354B2 (en) | 2002-07-15 | 2005-05-31 | Hoffman-La Roche Inc. | 3-phenyl-propionamido, 3-phenyl-acrylamido and 3-phenyl-propynamido derivatives |
US6846832B2 (en) | 2002-08-07 | 2005-01-25 | Hoffman-La Roche Inc. | 2,3-dihydro-isoindol-1-one derivatives |
MY134480A (en) | 2002-09-20 | 2007-12-31 | Hoffmann La Roche | 4-pyrrolidino-phenyl-benzyl ether derivatives |
JP2006056781A (ja) * | 2002-11-15 | 2006-03-02 | Bioserentack Co Ltd | 界面活性剤を含む固形化製剤 |
AU2003293798B8 (en) | 2002-12-13 | 2009-02-12 | F. Hoffmann-La Roche Ag | 3H-quinazolin-4-one derivatives |
AU2004208483B8 (en) | 2003-01-31 | 2008-04-03 | F. Hoffmann-La Roche Ag | Crystalline modifications of 2-(3,5-bis-trifluoromethyl-phenyl)-N-[6-(1,1-dioxo-1lamda6-thiomorpholin-4-yl)-4-(4-fluoro-2-methyl-phenyl)-pyridin-3-yl]-N-methyl-isobutyramide |
FR2851918B1 (fr) * | 2003-03-06 | 2006-06-16 | Poudre impregnee ameliorant la biodisponibilite et/ou la solubilite et procede de fabrication | |
US20060068010A1 (en) * | 2004-09-30 | 2006-03-30 | Stephen Turner | Method for improving the bioavailability of orally delivered therapeutics |
-
2006
- 2006-02-16 BR BRPI0606187-7A patent/BRPI0606187A2/pt not_active IP Right Cessation
- 2006-02-16 EP EP06706996A patent/EP1855655A2/en not_active Ceased
- 2006-02-16 CN CNA2006800061155A patent/CN101128189A/zh active Pending
- 2006-02-16 CA CA002598762A patent/CA2598762A1/en not_active Abandoned
- 2006-02-16 AU AU2006218193A patent/AU2006218193A1/en not_active Abandoned
- 2006-02-16 KR KR1020077019272A patent/KR20070094666A/ko active Search and Examination
- 2006-02-16 WO PCT/EP2006/001395 patent/WO2006089674A2/en active Application Filing
- 2006-02-16 JP JP2007556532A patent/JP2008531509A/ja active Pending
- 2006-02-16 EP EP10179258A patent/EP2281556A1/en not_active Withdrawn
- 2006-02-16 RU RU2007129642/15A patent/RU2007129642A/ru not_active Application Discontinuation
- 2006-02-16 NZ NZ560232A patent/NZ560232A/en not_active IP Right Cessation
- 2006-02-16 MX MX2007009571A patent/MX2007009571A/es not_active Application Discontinuation
- 2006-02-16 UA UAA200710576A patent/UA90708C2/ru unknown
- 2006-02-17 US US11/357,303 patent/US20060193910A1/en not_active Abandoned
- 2006-02-23 AR ARP060100652A patent/AR055561A1/es not_active Application Discontinuation
- 2006-02-23 TW TW095106135A patent/TW200640502A/zh unknown
-
2007
- 2007-08-02 IL IL185011A patent/IL185011A0/en unknown
- 2007-08-03 ZA ZA200706495A patent/ZA200706495B/xx unknown
- 2007-08-07 CR CR9292A patent/CR9292A/es not_active Application Discontinuation
- 2007-08-08 NO NO20074092A patent/NO20074092L/no not_active Application Discontinuation
- 2007-08-24 MA MA30164A patent/MA29268B1/fr unknown
-
2009
- 2009-08-17 US US12/542,163 patent/US20090304795A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
AU2006218193A1 (en) | 2006-08-31 |
RU2007129642A (ru) | 2009-03-27 |
ZA200706495B (en) | 2008-10-29 |
CA2598762A1 (en) | 2006-08-31 |
TW200640502A (en) | 2006-12-01 |
EP1855655A2 (en) | 2007-11-21 |
IL185011A0 (en) | 2007-12-03 |
NO20074092L (no) | 2007-09-04 |
US20060193910A1 (en) | 2006-08-31 |
CR9292A (es) | 2010-04-21 |
UA90708C2 (ru) | 2010-05-25 |
CN101128189A (zh) | 2008-02-20 |
EP2281556A1 (en) | 2011-02-09 |
MA29268B1 (fr) | 2008-02-01 |
JP2008531509A (ja) | 2008-08-14 |
NZ560232A (en) | 2010-11-26 |
WO2006089674A3 (en) | 2007-02-08 |
WO2006089674A2 (en) | 2006-08-31 |
KR20070094666A (ko) | 2007-09-20 |
AR055561A1 (es) | 2007-08-22 |
US20090304795A1 (en) | 2009-12-10 |
MX2007009571A (es) | 2007-09-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0606187A2 (pt) | comprimidos com capacidade de dispersão da substáncia do fármaco melhorada | |
HRP20192064T1 (hr) | Formulacije apiksabana | |
Agrawal et al. | Hydrotropic solubilization of nimesulide for parenteral administration | |
Spanakis et al. | Controlled release of 5-fluorouracil from microporous zeolites | |
Jain | Solubilization of indomethacin using hydrotropes for aqueous injection | |
AR038880A1 (es) | Composiciones farmaceuticas en granulos de liberacion inmediata y un proceso continuo para prepararlas | |
CN105555258A (zh) | 包含无定形达格列净的制剂 | |
PE20061449A1 (es) | Composiciones farmaceuticas comprendiendo imatinib y un retardador de liberacion | |
BRPI0608853B8 (pt) | composições farmacêuticas e processo para a fabricação de microgrânulos de rifaximina gastrorresistentes | |
DE102005026755A1 (de) | Herstellung von festen Lösungen schwerlöslicher Wirkstoffe durch Kurzzeitüberhitzung und schnelle Trocknung | |
BRPI0812064B8 (pt) | formulação farmacêutica na forma de aglomerados, comprimidos, e, processo para a produção de uma formulação farmacêutica | |
WO2012051426A3 (en) | Aggregate nanoparticulate medicament formulations, manufacture and use thereof | |
BRPI0707044B8 (pt) | comprimido matricial insolúvel em água e processo de fabricação de comprimidos matriciais | |
MY139086A (en) | Use of debranched starch in extrusion-spheronization pharmaceutical pellets | |
AR062509A1 (es) | Proceso para preparar comprimidos de dihidrocloruro de pramipexol | |
Dong et al. | Clay as a matrix former for spray drying of drug nanosuspensions | |
BRPI0518786A2 (pt) | formulaÇço farmacÊutica, processo para preparar uma formulaÇço farmacÊutica, produto, e, cÁpsula ou tablete | |
Krupa et al. | The influence of the API properties on the ODTs manufacturing from co-processed excipient systems | |
WO2008049633A3 (en) | Spray-freeze-drying process for the preparation of pellets comprising percolation drying | |
AR066000A1 (es) | Procedimiento para preparar comprimidos de dihidrocloruro de pramipexol | |
BRPI0518847A2 (pt) | processo para a preparaÇço de uma forma farmacÊutica sàlida oralmente dispersÁvel, e, forma farmacÊutica sàlida oralmente dispersÁvel | |
Jeevana et al. | Development and evaluation of gelatin microspheres of tramadol hydrochloride | |
WO2007072497A3 (en) | Stabilized pharmaceutical composition of pramipexole and method of preparation thereof | |
BR112013021527A2 (pt) | métodos para a produção de grânulos agroquímicos | |
Manukonda et al. | Solid dispersions-an approach to enhance the dissolution rate of Clopidogrel bisulphate |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 7A ANUI DADE. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2208 DE 30/04/2013. |